Affiliate files Form 144 to sell 3,385 shares

Affiliate filed a Form 144 reporting a proposed sale of 3,385 shares.

Rhea-AI Filing Summary

Affiliate filed a Form 144 reporting a proposed sale of 3,385 shares. The filing lists the securities to be sold as 3,385 shares tied to restricted stock vesting dated 05/08/2026. The excerpt also itemizes multiple past sales by David Mountcastle on various dates in 2026.

Insights

Securities Attorney

Routine Form 144 notice of proposed affiliate sale; disclosure-focused, not a market event.

The filing records a proposed sale of 3,385 shares from restricted stock vesting dated 05/08/2026. Form 144 is a regulatory notice required when affiliated holders intend to sell restricted or control securities.

Cash‑flow treatment and method of sale are not specified in the excerpt; subsequent transactional details will appear in broker/dealer reports or Form 4/Form 5 filings if and when sales occur.

Key Figures

Proposed sale: 3,385 shares Historical sale: 5,361 shares Historical sale: 7,179 shares +2 more

5 metrics

Proposed sale 3,385 shares Securities to be sold; Restricted Stock Vesting dated <date> 05/08/2026

Historical sale 5,361 shares Sale date <date> 02/26/2026 by David Mountcastle

Historical sale 7,179 shares Sale date <date> 05/01/2026 by David Mountcastle

Historical sale 1,206 shares Sale date <date> 05/04/2026 by David Mountcastle

Broker/dealer listed Fidelity Brokerage Services LLC Broker name and address shown on the filing

Key Terms

Form 144, Restricted Stock Vesting, Issuer, Filer / Broker

4 terms

Form 144 regulatory

"Form type line showing the filing is a Form 144 notice"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Securities To Be Sold entry: 'Restricted Stock Vesting' dated 05/08/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Issuer legal

"Securities To Be Sold entry lists 'Issuer' as transaction party"

Filer / Broker market

"Fidelity Brokerage Services LLC appears with address and NASDAQ listing"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PRVA's Form 144 report?

The Form 144 reports a proposed sale of 3,385 shares tied to restricted stock vesting dated 05/08/2026. It is a regulatory notice by an affiliate, not proof of a completed sale.

Who is listed as selling in the filing for PRVA?

The filing lists an affiliate holder and shows multiple past sales by David Mountcastle on dates in 2026. The proposed sale of 3,385 shares is linked to the issuer via vesting.

Does the Form 144 show proceeds or sale method for PRVA shares?

The excerpt does not state proceeds or the method of sale. The entry labels the transaction as Restricted Stock Vesting with the issuer indicated; sale mechanics are not provided in the excerpt.

Are the listed earlier transactions in 2026 completed sales?

The excerpt lists historical sale entries by date with share counts and dollar figures for 2026, which appear to be completed transactions. Each line shows a date, share quantity, and a dollar amount.

Will this Form 144 change PRVA's outstanding share count?

Filing a Form 144 is a notice of intent to sell; it does not itself change outstanding shares. Any change would occur only if and when the securities are sold and reported in subsequent filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 03:29 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001858396
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Privia Health Group, Inc.
SEC File Number	001-40365
Address of Issuer	950 N. GLEBE RD., SUITE 700 ARLINGTON VIRGINIA 22203
Phone	571-366-8850
Name of Person for Whose Account the Securities are To Be Sold	Mountcastle David
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3385	76512.85	126012374	05/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/08/2026	Restricted Stock Vesting	Issuer			3385	05/08/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	02/26/2026	5361	134030.87
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	02/27/2026	7697	192798.08
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/06/2026	5177	119852.73
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/09/2026	5829	133158.26
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/12/2026	6453	141317.47
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/13/2026	6565	141309.66
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/16/2026	6391	141303.73
David Mountcastle 950 N. Glebe Rd Suite 700 Arlington VA 22203	Common	04/02/2026	5566	116055.55
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	05/01/2026	7179	179680.69
David Mountcastle 950 N. Glebe Rd Suite 700 Arlington VA 22203	Common	05/04/2026	1206	30150.00

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	05/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Mountcastle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)